The Surmount-1 research of tirzepatide in people with prediabetes is the business’s lengthiest, lasting 176 weeks.
发布者:BY MARIUS AMBAKK BJORKEDAL,转转请注明出处:https://robotalks.cn/eli-lillys-obesity-candidate-reduces-diabetes-risk-by-up-to-94/
The Surmount-1 research of tirzepatide in people with prediabetes is the business’s lengthiest, lasting 176 weeks.
发布者:BY MARIUS AMBAKK BJORKEDAL,转转请注明出处:https://robotalks.cn/eli-lillys-obesity-candidate-reduces-diabetes-risk-by-up-to-94/